Find More Contacts for Transcept Pharmaceuticals
Protected Content
Non-Management
1 email found
View contacts for Transcept Pharmaceuticals to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email info@transcept.com
  • Phone Number (510) 215-3500

Transcept Pharmaceuticals, Inc. uses its proprietary delivery system to enhance the penetration of drugs, significantly speeding their onset of action. Transcept is developing rapid-acting versions of several major market pharmaceuticals. Hamilton co-invested in the company's first institutional round of funding alongside Montreaux Equity

Partners, Peninsula Equity Partners and Vivo Ventures. Investors in subsequent financing rounds include these firms, and New Leaf Venture Partners, Interwest Partners and New Enterprise Associates.

Lists Featuring This Company

Hercules Capital Portfolio Companies
215 Number of Organizations • $69.5B Total Funding Amount • 2,076 Number of Investors
Acquired San Francisco Bay Area Companies
8,785 Number of Organizations • $250.7B Total Funding Amount • 30,184 Number of Investors
Closed Biotechnology Companies
3,634 Number of Organizations • $76.5B Total Funding Amount • 6,411 Number of Investors
Neuroscience Companies that Exited
88 Number of Organizations • $8.2B Total Funding Amount • 344 Number of Investors
Transcept Pharmaceuticals was acquired by Paratek Pharmaceuticals on Oct 30, 2014.

Frequently Asked Questions

Where is Transcept Pharmaceuticals's headquarters? Transcept Pharmaceuticals is located in Richmond, California, United States.Who invested in Transcept Pharmaceuticals? Transcept Pharmaceuticals has 9 investors including Hercules Capital and Peninsula Ventures.How much funding has Transcept Pharmaceuticals raised to date? Transcept Pharmaceuticals has raised .When was the last funding round for Transcept Pharmaceuticals? Transcept Pharmaceuticals closed its last funding round on Mar 8, 2007 from a Series D round.